ArticleInternational journal of molecular sciences2022

Combined Therapy with a CCR2/CCR5 Antagonist and FGF21 Analogue Synergizes in Ameliorating Steatohepatitis and Fibrosis.

Tobias Puengel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.